Captopril (SQ 14,225) (d-3-mercapto-2-methylpropanoyl-l-proline): A novel orally active inhibitor of angiotensin-converting enzyme and antihypertensive agent
- 31 December 1978
- journal article
- review article
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 21 (3) , 183-194
- https://doi.org/10.1016/0033-0620(78)90024-5
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Inhibition of angiotensin converting enzyme by SQ 14,225 in conscious rabbitsEuropean Journal of Pharmacology, 1977
- Central cardiovascular effects of SQ 14,225, an angiotensin-converting enzyme inhibitor in chloralose-anesthetized catsEuropean Journal of Pharmacology, 1977
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977
- A SPECIFIC ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME IN MANThe Lancet, 1977
- Angiotensin-Converting Enzyme and the Regulation of Vasoactive PeptidesAnnual Review of Biochemistry, 1976
- Conversion of angiotensin I to angiotensin IIThe American Journal of Medicine, 1976
- The biochemistry of the renin-angiotensin system and its role in hypertensionThe American Journal of Medicine, 1976
- Inhibition by SQ 20881 of vasopressor response to angiotensin I in conscious animalsEuropean Journal of Pharmacology, 1973
- A technique for prolonged, continuous recording of blood pressure of unrestrained ratsCardiovascular Research, 1972
- Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesisBiochemistry, 1971